PT  - JOURNAL ARTICLE
AU  - Lynn Fox
AU  - Lavinia Mcleod
AU  - Anne-Marie Russell
AU  - Colin Edwards
AU  - Katherine O'Reilly
TI  - Single-arm observational study of a mobile app + home spirometry in idiopathic pulmonary fibrosis
AID  - 10.1183/13993003.congress-2020.787
DP  - 2020 Sep 07
TA  - European Respiratory Journal
PG  - 787
VI  - 56
IP  - suppl 64
4099  - http://erj.ersjournals.com/content/56/suppl_64/787.short
4100  - http://erj.ersjournals.com/content/56/suppl_64/787.full
SO  - Eur Respir J2020 Sep 07; 56
AB  - Daily home spirometry may be useful in assessing idiopathic pulmonary fibrosis (IPF). patientMpower (pMp) is a mobile application for IPF patients to record medicines adherence, activity, FVC, dyspnea (mMRC score), impact of IPF on daily life [Patient Reported Outcome Measure (PROM)] & other outcomes. pMp captures home spirometry via Bluetooth-linked Spirobank Smart spirometer (MIR, Rome, Italy). IPF patients attending a nurse-led clinic were asked to take part in this prospective, open, single-arm study (NCT03544598).Objectives: assess (1) longitudinal trends of home FVC & PROM (2) correlation of home- vs. clinic-measured FVC & PROM. pMp & spirometer pairing installed on patients’ smartphones at baseline. Patients recorded FVC (seated; 1/d) & PROM (1/wk) on pMp until next routine clinic visit (usual care throughout). Other data (e.g. mMRC, symptoms, oximetry, oxygen flow-rate, adherence, weight) recorded on pMp if they wished. FVC, mMRC & PROM assessed at clinic at start & end. 20 patients entered [16 male; age: 66.6±9.0Y, baseline predicted clinic FVC: 91.9%±17.0%, median mMRC: 2]. Baseline scores indicated impact of IPF on all PROM domains. 14 completed to date. Baseline clinic FVC: 3.36±0.81L with FVC: 3.37±0.89L at follow-up. Stability was reflected in PROM scores. Median follow-up: 117d [interquartile range (IQR): 111-125] & adherence to home spirometry: 87% (IQR: 39-94%). In questionnaires, 8/9 patients wanted to continue pMp & would recommend to others. 9/14 patients continued pMp+home spirometry after study end. IPF patients may wish to use pMp to record spirometry & other outcomes as part of usual care. Daily home spirometry was feasible & acceptable for most patients.FootnotesCite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 787.This abstract was presented at the 2020 ERS International Congress, in session “Respiratory viruses in the "pre COVID-19" era”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).